Alogliptin Associated With Lower Fracture Risk Than Linagliptin, Saxagliptin in T2D
Alogliptin Associated With Lower Bone Fracture Risk in T2D
Postprandial hypoglycemia may occur after Roux-en-Y gastric bypass in patients with type 2 diabetes, independent from diabetes remission.
Approximately 50% of deaths in people with type 2 diabetes worldwide, and approximately two-thirds of deaths in people with type 2 diabetes in the US are caused by cardiovascular disease.
Dapaglifozin and vildagliptin impact cardio-metabolic processes differently.